""

Neuroendocrine tumors

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Metastatic Disease: First-Line-Therapy

Title: A Randomized, Multi-center, Open-label, Active-controlled Phase 3 Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) Versus Octreotide LAR or Lanreotide ATG in Patients With GEP-NET
Phase: III
Contact: Elisabeth Lawrence / Kontaktperson
Email-Address: Elisabeth.Lawrence@med.uni-heidelberg.de
Clinical Investigator: Dr. Leonidas Apostolidis
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05050942
EudraCT-Number: Siehe EU klinisches Studienregister 2021-000849-40
Title: CABONEN - A Phase II Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3
Phase: II
Contact: Elisabeth Lawrence / Kontaktperson
Email-Address: Elisabeth.Lawrence@med.uni-heidelberg.de
Clinical Investigator: Dr. Leonidas Apostolidis
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT04524208
EudraCT-Number: Siehe EU klinisches Studienregister 2020-002541-41

Metastatic Disease: Follow-Up Treatment

Title: A Phase II, Open-label, Multicenter Trial to Investigate the Clinical Activity and Safety of Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3).
Phase: II
Contact: Elisabeth Lawrence / Kontaktperson
Email-Address: Elisabeth.Lawrence@med.uni-heidelberg.de
Clinical Investigator: Dr. Leonidas Apostolidis
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05289856
EudraCT-Number: Siehe EU klinisches Studienregister 2021-000986-34
Title: CABONEN - A Phase II Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3
Phase: II
Contact: Elisabeth Lawrence / Kontaktperson
Email-Address: Elisabeth.Lawrence@med.uni-heidelberg.de
Clinical Investigator: Dr. Leonidas Apostolidis
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT04524208
EudraCT-Number: Siehe EU klinisches Studienregister 2020-002541-41

Surgical Study

There are currently no studies available

Radiotherapy Study

There are currently no studies available

Other study

There are currently no studies available